> Both countries with socialized medicine and yet they still didn't come up with a cure.
This is misleading. The original post was about medical research, which neither in Greece nor in England is any more "socialized" than elsewhere. They might have national health services, but those buy their medicines from the same private actors as any hospital in the United States.
Also note that the original article is specifically not about profit-driven R&D but about a donation-funded, non-profit venture. The (hopeful!) success of such a venture does not really translate well into an argument for private, for-profit medicine R&D.
You could argue that it's the raw capitalistic drive of SV that is uniquely able to generate the wealth necessary for such non-profit ventures, ok, fine (there are also counter arguments to this), but this was not really the point of the original comment.
As the article argues, there's no profit to be made because of lack of patentability. If this is the case, maybe an adjustment in incentives on the side of the law would fix this and make the private sector interested.
A lot of the big medical innovations still come from the private sector. The question is only whether we can get the interests aligned here.
This is misleading. The original post was about medical research, which neither in Greece nor in England is any more "socialized" than elsewhere. They might have national health services, but those buy their medicines from the same private actors as any hospital in the United States.
Also note that the original article is specifically not about profit-driven R&D but about a donation-funded, non-profit venture. The (hopeful!) success of such a venture does not really translate well into an argument for private, for-profit medicine R&D.
You could argue that it's the raw capitalistic drive of SV that is uniquely able to generate the wealth necessary for such non-profit ventures, ok, fine (there are also counter arguments to this), but this was not really the point of the original comment.